Pioglitazone hydrochloride

IUPAC Name: 5-[[4-[2-(5-Ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione hydrochloride
Molecular Formula: C₁₉H₂₁ClN₂O₃S
Molecular Weight: 392.90 g/mol
Canonical SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl
InChI: InChI=1/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H
Classification Code: Antidiabetic
Product Categories: Active Pharmaceutical Ingredients; Antidiabetic; Diabetes; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds;API's; Pioglitazone
H-Bond Donor: 2
H-Bond Acceptor: 4
Rotatable Bond Count: 7
Tautomer Count: 10
Exact Mass: 392.096141
MonoIsotopic Mass: 392.096141
Topological Polar Surface Area: 68.3
Heavy Atom Count: 26
Complexity: 466
Melting Point: 193-194 °C
Flash Point: 301.8 °C
Enthalpy of Vaporization: 86.19 kJ/mol
Boiling Point: 575.4 °C at 760 mmHg
Vapour Pressure of Pioglitazone HCl (CAS NO.112529-15-4): 3.03E-13 mmHg at 25 °C

 Pioglitazone HCl (CAS NO.112529-15-4) is used as an antidiabetic.

Hazard Codes: Xi
Risk Statements: 36/38 
R36/38: Irritating to eyes and skin.
Safety Statements of Pioglitazone HCl (CAS NO.112529-15-4): 22-24/25 
S22: Do not breathe dust. 
S24/25: Avoid contact with skin and eyes.

  Pioglitazone HCl (CAS NO.112529-15-4), its Synonyms are 2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)- ; (+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride ; Pioglitazone hydrochloride ; Actos . It is colourless prisms.